152 related articles for article (PubMed ID: 27900085)
1. ID1 upregulation and FoxO3a downregulation by Epstein-Barr virus-encoded LMP1 in Hodgkin's lymphoma.
Ikeda JI; Wada N; Nojima S; Tahara S; Tsuruta Y; Oya K; Morii E
Mol Clin Oncol; 2016 Nov; 5(5):562-566. PubMed ID: 27900085
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Id1 by Epstein-Barr virus-encoded LMP1 confers resistance to TGFbeta-mediated growth inhibition.
Lo AK; Dawson CW; Lo KW; Yu Y; Young LS
Mol Cancer; 2010 Jun; 9():155. PubMed ID: 20565867
[TBL] [Abstract][Full Text] [Related]
3. Expression of FoxO3a in clinical cases of malignant lymphoma.
Ikeda J; Tian T; Wang Y; Hori Y; Honma K; Wada N; Morii E
Pathol Res Pract; 2013 Nov; 209(11):716-20. PubMed ID: 24021689
[TBL] [Abstract][Full Text] [Related]
4. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus Latent Membrane Protein 1 Regulates Host B Cell MicroRNA-155 and Its Target FOXO3a
Hatton O; Smith MM; Alexander M; Mandell M; Sherman C; Stesney MW; Hui ST; Dohrn G; Medrano J; Ringwalt K; Harris-Arnold A; Maloney EM; Krams SM; Martinez OM
Front Microbiol; 2019; 10():2692. PubMed ID: 32038504
[TBL] [Abstract][Full Text] [Related]
6. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and Hodgkin's lymphoma.
Andersson J
Herpes; 2006 May; 13(1):12-6. PubMed ID: 16732997
[TBL] [Abstract][Full Text] [Related]
8. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.
Siegler G; Kremmer E; Gonnella R; Niedobitek G
Mol Pathol; 2003 Jun; 56(3):156-61. PubMed ID: 12782762
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease.
Meij P; Vervoort MB; Bloemena E; Schouten TE; Schwartz C; Grufferman S; Ambinder RF; Middeldorp JM
J Med Virol; 2002 Nov; 68(3):370-7. PubMed ID: 12226824
[TBL] [Abstract][Full Text] [Related]
11. Loss of P16 Protein Expression and Its Association with Epstein-Barr Virus LMP-1 Expression in Hodgkin's Lymphoma.
Irshaid F; Tarawneh K; Alshdefat A; Dilmi F; Jaran A; Al-Hadithi R; Al-Khatib A
Iran J Cancer Prev; 2013; 6(2):78-84. PubMed ID: 25250115
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
13. [Infection status and prognostic significance analysis of Epstein-Barr virus in 207 cases with newly diagnosed Hodgkin's lymphoma].
Kang S; Qin Y; He X; Zhou S; Han X; Liu P; Dong M; Zhou L; Yang J; Yang S; Zhang C; Gui L; Shi Y
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2594-8. PubMed ID: 26711606
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin's lymphoma after EBV infection].
Ping LY; Ding N; Shi YF; Sun L; Zheng W; Xie Y; Wang XP; Tu MF; Lin NJ; Ying ZT; Liu WP; Deng LJ; Zhan C; Tian L; Feng LX; Song YQ; Zhu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):78-84. PubMed ID: 24598656
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.
Deacon EM; Pallesen G; Niedobitek G; Crocker J; Brooks L; Rickinson AB; Young LS
J Exp Med; 1993 Feb; 177(2):339-49. PubMed ID: 8381153
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
Vockerodt M; Tesch H; Kube D
Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
[TBL] [Abstract][Full Text] [Related]
18. Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice.
Lee EK; Joo EH; Song KA; Choi B; Kim M; Kim SH; Kim SJ; Kang MS
Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13081-6. PubMed ID: 26438862
[TBL] [Abstract][Full Text] [Related]
19. Geographic sequence variation of latent membrane protein 1 gene of Epstein-Barr virus in Hodgkin's lymphomas.
Lin JC; Lin SC; Luppi M; Torelli G; Mar EC
J Med Virol; 1995 Feb; 45(2):183-91. PubMed ID: 7775937
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
Liebowitz D
N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
